Literature DB >> 21365188

Update: modern approaches to the treatment of localized esophageal cancer.

James Welsh1, Arya Amini, Anna Likhacheva, Jeremy Erasmus J, Daniel Gomez, Marta Davila, Reza J Mehran, Ritsuko Komaki, Zhongxing Liao, Wayne L Hofstetter, Jeffrey Lee H, Manoop S Bhutani, Jaffer A Ajani.   

Abstract

The optimal treatment strategy for esophageal cancer continues to be a topic of debate. Improvements in chemotherapy drugs, surgical techniques, and radiotherapy planning and delivery have led to the design of treatment approaches that are specific to both the stage of the tumor and the overall performance status of the patient. Surgery continues to be the standard treatment option for localized disease, but multimodality treatments that include radiation and chemotherapy with surgery are increasingly used. The next few years will continue to see improvements in radiation techniques, especially proton beam treatment; the development of additional minimally invasive surgical approaches to minimize postoperative side effects; and the discovery of molecular biomarkers to help specifically target treatment of esophageal cancer in individual patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21365188      PMCID: PMC4086148          DOI: 10.1007/s11912-011-0158-z

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  66 in total

1.  Dietary factors and the risk of squamous cell esophageal cancer among black and white men in the United States.

Authors:  L M Brown; C A Swanson; G Gridley; G M Swanson; D T Silverman; R S Greenberg; R B Hayes; J B Schoenberg; L M Pottern; A G Schwartz; J M Liff; R Hoover; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1998-10       Impact factor: 2.506

2.  Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer.

Authors:  Val J Lowe; Fargol Booya; J G Fletcher; Mark Nathan; Eric Jensen; Brian Mullan; Eric Rohren; Maurits J Wiersema; Enrique Vazquez-Sequeiros; Joseph A Murray; Mark S Allen; Michael J Levy; Jonathan E Clain
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

3.  Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals.

Authors:  Thomas W Rice; Valerie W Rusch; Hemant Ishwaran; Eugene H Blackstone
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

4.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

5.  Circumferential and focal ablation of Barrett's esophagus containing dysplasia.

Authors:  Virender K Sharma; H Jae Kim; Ananya Das; Christopher D Wells; Cuong C Nguyen; David E Fleischer
Journal:  Am J Gastroenterol       Date:  2009-01-27       Impact factor: 10.864

6.  Esophagogastrectomy. A safe, widely applicable, and expeditious form of palliation for patients with carcinoma of the esophagus and cardia.

Authors:  F H Ellis; S P Gibb; E Watkins
Journal:  Ann Surg       Date:  1983-10       Impact factor: 12.969

7.  Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients.

Authors:  J J Gondrie; R E Pouw; C M T Sondermeijer; F P Peters; W L Curvers; W D Rosmolen; K K Krishnadath; F Ten Kate; P Fockens; J J Bergman
Journal:  Endoscopy       Date:  2008-05       Impact factor: 10.093

8.  Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.

Authors:  David P Kelsen; Katryn A Winter; Leonard L Gunderson; Joanne Mortimer; Norman C Estes; Daniel G Haller; Jaffer A Ajani; Walter Kocha; Bruce D Minsky; Jack A Roth; Christopher G Willett
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544

9.  Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.

Authors:  I E Katsoulis; W L Wong; A K Mattheou; N Damani; J Chambers; J I Livingstone
Journal:  Int J Surg       Date:  2007-06-03       Impact factor: 6.071

10.  Staging investigations for oesophageal cancer: a meta-analysis.

Authors:  E P M van Vliet; M H Heijenbrok-Kal; M G M Hunink; E J Kuipers; P D Siersema
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

View more
  2 in total

1.  A Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal Cancer.

Authors:  Li-Li Zhu; Ling Yuan; Hui Wang; Lin Ye; Gui-Ying Yao; Cui Liu; Niu-Niu Sun; Xiao-Jing Li; Shi-Cong Zhai; Ling-Juan Niu; Jun-Bo Zhang; Hong-Long Ji; Xiu-Min Li
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

2.  Oesophageal cancer metastases: An observational study of a more aggressive approach.

Authors:  Lianne Pickett; Mary Dunne; Orla Monaghan; Liam Grogan; Oscar Breathnach; Thomas N Walsh
Journal:  World J Gastrointest Surg       Date:  2022-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.